Data / Form D filings / ARISAPH PHARMACEUTICALS INC
ARISAPH PHARMACEUTICALS INC: Form D filing
ARISAPH PHARMACEUTICALS INC, a pharmaceuticals company in Boston, MA, filed a Form D with the SEC in 2013. The latest, on November 1, 2013, reports $10 million sold of a $20 million offering to 1 investor.
Find out what ARISAPH PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 HIGH STREET #1202, Boston, MA, 02110
- Phone
- (617) 292-3306
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1270300
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 1, 2013 | New notice | $20,000,000 | $10,000,000 | $10,000,000 | 1 | Oct 17, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Bachovchin | Executive Officer, Director | |
| Madias Nicolaos | Director | |
| Steven Jaharis | Director | |
| Robert Baldini | Director | |
| Claude Benedict | Executive Officer | |
| Thomas Koestler | Director | |
| Christopher Kiritsy | Executive Officer, Director | |
| Joseph Suarez | Executive Officer | |
| Antonio Gotto | Director | |
| Rex Roten | Director | |
| Michael Jaharis | Director | |
| Kevin Ferro | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Oct 28, 2013 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ARISAPH PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.